AAAAAA

   
Results: 1-5 |
Results: 5
4-hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: The effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters
Authors: Hagen, SE Domagala, J Gajda, C Lovdahl, M Tait, BD Wise, E Holler, T Hupe, D Nouhan, C Urumov, A Zeikus, G Zeikus, E Lunney, EA Pavlovsky, A Gracheck, SJ Saunders, J VanderRoest, S Brodfuehrer, J
Citation: Se. Hagen et al., 4-hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: The effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters, J MED CHEM, 44(14), 2001, pp. 2319-2332
5,6-dihydropyran-2-ones possessing various sulfonyl functionalities: Potent nonpeptidic inhibitors of HIV protease
Authors: Boyer, FE Prasad, JVNV Domagala, JM Ellsworth, EL Gajda, C Hagen, SE Markoski, LJ Tait, BD Lunney, EA Palovsky, A Ferguson, D Graham, N Holler, T Hupe, D Nouhan, C Tummino, PJ Urumov, A Zeikus, E Zeikus, G Gracheck, SJ Sanders, JM VanderRoest, S Brodfuehrer, J Iyer, K Sinz, M Gulnik, SV Erickson, JW
Citation: Fe. Boyer et al., 5,6-dihydropyran-2-ones possessing various sulfonyl functionalities: Potent nonpeptidic inhibitors of HIV protease, J MED CHEM, 43(5), 2000, pp. 843-858
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor
Authors: Prasad, JVNV Boyer, FE Domagala, JM Ellsworth, EL Gajda, C Hamilton, HW Hagen, SE Markoski, LJ Steinbaugh, BA Tait, BD Humblet, C Lunney, EA Pavlovsky, A Rubin, JR Ferguson, D Graham, N Holler, T Hupe, D Nouhan, C Tummino, PJ Urumov, A Zeikus, E Zeikus, G Gracheck, SJ Saunders, JM VanderRoest, S Brodfuehrer, J Iyer, K Sinz, M Gulnik, SV Erickson, JW
Citation: Jvnv. Prasad et al., Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor, BIO MED CH, 7(12), 1999, pp. 2775-2800
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety.
Authors: Prasad, JVNV Markoski, LJ Boyer, FE Domagala, JM Ellsworth, EL Gajda, C Hagen, SE Tait, BD Lunney, EA Tummino, PJ Ferguson, D Holler, T Hupe, D Nouhan, C Gracheck, SJ VanderRoest, S Saunders, J Iyer, K Sinz, M
Citation: Jvnv. Prasad et al., Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing a novel and achiral 3-(2-t-butyl-5-methyl-4-sulfamate)phenylthio moiety., BIOORG MED, 9(15), 1999, pp. 2217-2222
Nonpeptidic HIV protease inhibitors: 6-alkyl-5, 6-dihydroyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl, 5-methylphenyl trio) moiety: Antiviral activities and pharmacokinetic properties
Authors: Prasad, JVNV Boyer, FE Domagala, JM Ellsworth, EL Gajda, C Hagen, SE Markoski, LJ Tait, BD Lunney, EA Tummino, PJ Ferguson, D Holler, T Hupe, D Nouhan, C Gracheck, SJ VanderRoest, S Saunders, J Iyer, K Sinz, M Brodfuehrer, J
Citation: Jvnv. Prasad et al., Nonpeptidic HIV protease inhibitors: 6-alkyl-5, 6-dihydroyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl, 5-methylphenyl trio) moiety: Antiviral activities and pharmacokinetic properties, BIOORG MED, 9(11), 1999, pp. 1481-1486
Risultati: 1-5 |